A water-soluble and near-infrared indomethacin-modified BODIPY photosensitizer for tumor-targeting photodynamic therapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Luminescence and Fluorescent Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (41)
Show source-provided references
1. Cancer statistics
2. Cancer statistics
3. Lung cancer immunotherapy: progress, pitfalls, and promises10.1186/s12943-023-01740-y ↗
4. Global research trends on Chinese patent drugs inducing programmed cell death in cancer: a bibliometric analysis (1998-2024)10.1007/s12672-025-02913-5 ↗
5. Nanomaterials in tumor immunotherapy: new strategies and challenges10.1186/s12943-023-01797-9 ↗
6. Tumor microenvironment
7. Editorial: drug repurposing for cancer treatment: current and future directions10.3389/fonc.2025.1550672 ↗
8. Emerging nanotechnology and advanced materials for cancer radiation therapy10.1002/adma.201700996 ↗
9. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
10. Manganese-based Tumor immunotherapy
11. Heterostructural nanoadjuvant CuSe/CoSe2 for potentiating ferroptosis and photoimmunotherapy through intratumoral blocked lactate efflux10.1021/jacs.2c12772 ↗
12. Orchestrating nitric oxide and carbon monoxide signaling molecules for synergistic treatment of MRSA infections
13. Luminescent quantum dots: synthesis, optical properties, bioimaging and toxicity10.1016/j.addr.2023.114830 ↗
14. Chemodynamic therapy via Fenton and Fenton-like nanomaterials: strategies and recent advances10.1002/smll.202103868 ↗
15. Clinical trials update in the photodynamic therapy strategy for treatment of choroidal melanoma: a review of literature10.1016/j.pdpdt.2025.104521 ↗
16. Conquering the hypoxia limitation for photodynamic therapy10.1002/adma.202103978 ↗
17. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application10.1039/D0CS00173B ↗
18. Tumor microenvironment as a therapeutic target in cancer10.1016/j.pharmthera.2020.107753 ↗
19. Tumor-microenvironment-responsive Cascade reactions by a cobalt-single-atom nanozyme for synergistic nanocatalytic chemotherapy10.1002/anie.202204502 ↗
20. The evolving tumor microenvironment From cancer initiation to metastatic outgrowth10.1016/j.ccell.2023.02.016 ↗
21. Semiconducting polymer nano-PROTACs for activatable photo-immunometabolic cancer therapy10.1038/s41467-021-23194-w ↗
22. Recent advances in fluorescent probes for cancer biomarker detection10.3390/molecules29051168 ↗
23. An enzyme-free and label-free ratiometric fluorescence signal amplification biosensor based on DNA-silver nanoclusters and catalytic hairpin assembly for tetracycline detection10.1016/j.snb.2023.135216 ↗
24. Activatable NIR-II organic fluorescent probes for bioimaging10.7150/thno.71359 ↗
25. Nanoscale photosensitizer with tumor-selective turn-on fluorescence and activatable photodynamic therapy treatment for COX-2 overexpressed cancer cells10.1039/D0TB02828B ↗
26. Platinum prodrug nanoparticles with COX-2 inhibition amplify pyroptosis for enhanced chemotherapy and immune activation of pancreatic cancer
27. Indomethacin-based near-infrared photosensitizer for targeted photodynamic cancer therapy10.1016/j.bioorg.2022.105758 ↗
28. COX-2-targeted fluorescent probe for ClO- monitoring in precise cancer detection10.1016/j.bioorg.2025.108164 ↗
29. COX-2 targeting and hypoxia activation of IMC-NTR for cancer diagnosis and therapeutics: in vitro and in vivo studies10.1016/j.snb.2025.137970 ↗
30. BODIPY conjugates with monoterpenoids for photodynamic diagnostics and therapy: design, spectral properties, photostability and antifungal activity10.1016/j.jphotochem.2025.116611 ↗
31. Molecular design of Monochromophore-Based bifunctional photosensitizers for simultaneous ratiometric oxygen reporting and photodynamic cancer therapy10.1021/acs.analchem.1c02485 ↗
32. Recent advances in targeting COX-2 for cancer therapy: a review10.1039/D5MD00196J ↗
33. Strategic functionalization of bromine and nitrogen at the bay region of perylene induces a heavy atom effect and promotes intersystem crossing10.1039/D5CP03115J ↗
34. Poly(photosensitizer) nanoparticles for enhanced in vivo photodynamic therapy by interrupting the π–π stacking and extending circulation time10.1021/acsami.9b04351 ↗
35. The Golgi apparatus as a strategic target in cancer: mechanisms, diagnosis and therapeutic opportunities10.1080/1061186X.2025.2527867 ↗
36. Albumin-based multidrug delivery system enriched in Golgi apparatus against metastatic breast cancer10.1007/s12274-022-5141-5 ↗
37. COX-2 inhibition mediated aggregation-induced emission photosensitizer target the Golgi apparatus for selective imaging of cancer cells and enhanced photodynamic therapy10.1016/j.dyepig.2023.111897 ↗
38. Cyclooxygenase-2-targeting fluorescent carbon dots for the selective imaging of Golgi apparatus10.1016/j.dyepig.2022.110213 ↗
39. A Nile blue based infrared fluorescent probe: imaging tumors that over-express cyclooxygenase-210.1039/C4CC08915D ↗
40. Aza-BODIPY probe for selective visualization of cyclooxygenase-2 in cancer cells10.1039/C9RA01948K ↗
41. The role of ROS in tumour development and progression10.1038/s41568-021-00435-0 ↗